淫羊藿及其化学成分在肿瘤治疗中的综合综述:传统应用、抗肿瘤作用、药代动力学、递送系统与毒理学
本文系统综述了淫羊藿的传统抗肿瘤应用、主要化学成分、抗肿瘤机制、药代动力学、毒理学及递送系统。淫羊藿黄酮和多糖可抑制肿瘤细胞增殖、诱导凋亡、促进自噬、降低耐药性并改善肿瘤免疫微环境,涉及消化系统和生殖系统肿瘤;纳米技术可提高其靶向抗肿瘤疗效,但临床研究仍需验证。
要点
- 淫羊藿黄酮和多糖对肝癌、结肠癌、胃癌、乳腺癌、宫颈癌和卵巢癌有抗肿瘤作用。
- 淫羊藿黄酮生物利用度低,纳米技术可增强靶向抗肿瘤疗效。
- 淫羊藿急性和长期毒性低,但肝毒性尤其体内研究仍需进一步明确。
核心结论
- 淫羊藿及其化学成分可抑制肿瘤发生和进展,但需进一步临床研究验证。
研究设计与样本
- 检索经典中药资源、PubMed、Web of Science、万方数据库和中国知网,系统总结和分析淫羊藿及其成分抗肿瘤的现有实验和临床研究。
主要发现
- 淫羊藿黄酮和多糖可抑制肿瘤细胞增殖、诱导凋亡、促进自噬、降低耐药性并改善肿瘤免疫微环境。
- 作用范围涉及消化系统肿瘤如肝癌、结肠癌、胃癌,以及生殖系统肿瘤如乳腺癌、宫颈癌、卵巢癌。
- 淫羊藿黄酮因快速吸收和消除导致生物利用度低,纳米技术可显著增强靶向抗肿瘤疗效。
临床怎么用
- 淫羊藿及其成分具有抗肿瘤潜力,但当前证据主要来自实验研究,临床应用于肿瘤治疗需进一步验证。
局限性
- 淫羊藿抗肿瘤的机制和安全性仍需进一步研究。
- 淫羊藿的肝毒性尤其体内研究需进一步明确,其代谢途径、分布和体内机制也需深入探索。
- 当前淫羊藿研究在有效生物活性成分、潜在药理作用和给药方法方面仍存在显著局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNIC PHARMACOLOGICAL RELEVANCE: Epimedium, recognized within traditional Chinese medicine (TCM) as a tonic, is noted for its role in enhancing kidney Yang, fortifying muscles and bones, and alleviating wind and dampness. It also exhibits therapeutic and preventive properties against cancer. This study systematically analyzes the botany, traditional uses, principal chemical components, antitumor mechanisms, pharmacokinetics, toxicology, and drug delivery systems of Epimedium. It aims to further prospect the antitumor capabilities of Epimedium based on existing research. AIM OF THE STUDY: This review aims to explore the traditional antitumor applications of Epimedium and the contemporary pharmacological actions of its chemical components, providing robust theoretical support for further elucidating Epimedium's antitumor mechanisms. It also offers a comprehensive view for the research and development of cancer treatments involving Epimedium. MATERIALS AND METHODS: We conducted searches in classical Chinese herbal medicine resources, PubMed, Web of Science, Wanfang Database, and China National Knowledge Infrastructure (CNKI) for studies on the antitumor effects of Epimedium and its components. Existing experimental and clinical studies were systematically summarized and analyzed to understand the mechanisms by which Epimedium treats cancer. RESULTS: In the realm of Chinese medicine, Epimedium is recognized for its cancer-treating capabilities. Besides its traditional effects, flavonoids and polysaccharides from Epimedium can inhibit tumor cell proliferation, induce apoptosis, promote autophagy, reduce drug resistance, and improve the tumor immune microenvironment (TIM), addressing cancers of the digestive system, such as liver, colon, and gastric cancers, and of the reproductive system, including breast, cervical, and ovarian cancers. Although the bioavailability of Epimedium flavonoids is low due to rapid absorption and elimination, the use of nanotechnology has significantly enhanced the efficacy of targeted antitumor therapies. Nevertheless, the mechanisms and safety of Epimedium in cancer treatment merit further investigation. Despite its low acute and long-term toxicity, additional research is required to clarify its hepatotoxicity, particularly in vivo, and to further explore its metabolic pathways, distribution, and mechanisms within the body. CONCLUSION: Epimedium and its chemical constituents have been shown to inhibit tumor initiation and progression, however, further clinical studies are required to validate these findings. Despite its potential, significant limitations remain in the current research on Epimedium, necessitating more comprehensive studies on its potent bioactive components, potential pharmacological effects, and administration methods.
引用
- Wang S, Wang H, Zhang Y, et al. Epimedium and its chemical constituents in cancer treatment: A comprehensive review of traditional applications, antitumor effects, pharmacokinetics, delivery systems, and toxicology. J Ethnopharmacol. 2025. PMID: 40185257. doi:10.1016/j.jep.2025.119738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。